Logo image
Synthetic Biology-Based Point-of-Care Diagnostics for Infectious Disease
期刊文章   開放取用(OA)   同儕審查

Synthetic Biology-Based Point-of-Care Diagnostics for Infectious Disease

Ting-Yen WeiChao-Min Cheng
Cell Chemical Biology, 卷.23(9), 頁碼.1056-1066
09/2016
PMID: 27662252

摘要

Biochemistry Molecular Medicine Molecular Biology Pharmacology Drug Discovery Clinical Biochemistry
Infectious diseases outpace all other causes of death in low-income countries, posing global health risks, laying stress on healthcare systems and societies, and taking an avoidable human toll. One solution to this crisis is early diagnosis of infectious disease, which represents a powerful way to optimize treatment, increase patient survival rate, and decrease healthcare costs. However, conventional early diagnosis methods take a long time to generate results, lack accuracy, and are known to seriously underperform with regard to fungal and viral infections. Synthetic biology offers a fast and highly accurate alternative to conventional infectious disease diagnosis. In this review, we outline obstacles to infectious disease diagnostics and discuss two emerging alternatives: synthetic viral diagnostic systems and biosensors. We argue that these synthetic biology-based approaches may overcome diagnostic obstacles in infectious disease and improve health outcomes.

檔案與連結 (1)

url
https://doi.org/10.1016/j.chembiol.2016.07.016檢視
已出版(紀錄版本) 開放

相關連結

指標

1 檢視次數

詳細資料

Logo image